A New Era in Oncology: Tennessee's $20 Million Leap into Radiopharmaceutical ResearchRead Now!

Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to DrugBank.com to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in

Drugs

Drugs
Targets
Pathways
Indications

Log in or create an account for full access to this data.

Malignant Liver Disease

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB01220	Rifaximin	2	Terminated	1

Stay up-to-date with the
latest from DrugBank!

Thank you
for subscribing!

Downloads

Data Library
Academic Downloads
Contact Sales

Learn More

Careers
Blog
Clinical API
Contact Sales

Support

Help Center
DrugBank Online FAQs
Contact Support
Citing DrugBank
Searching DrugBank
Other Databases
Data Sources

About

About DrugBank Online
Wishart Research Group
Statistics
Terms of Use
Privacy Policy

Use or redistribution of any DrugBank content or data requires a license and proper citations. Talk to sales for commercial licensing. Apply for an academic license.